Top Markets
Coin of the day
Abpro Corporation Abpro Corporation

Abpro Corporation

ABP
Ранг среди акций #39900
Abpro Holdings, Inc. is a biotechnology firm dedicated to creating... Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-100, designed to target breast, gastric, and colorectal cancers, and ABP-201, intended for the treatment of vascular diseases affecting the eye. The company has established strategic alliances with Abpro Bio Co. Ltd and NJCTTQ. Originally known as Abpro Corporation, the company officially changed its name to Abpro Holdings, Inc. in November 2024. Incorporated in 2004, Abpro Holdings, Inc. operates from its headquarters in Woburn, Massachusetts.
Цена акции
$0.158
Последняя синхронизация: 2026-04-06
Рыночная капитализация
$302.92K
Изменение (1 день)
16.18%
Изменение (1 год)
-97.91%
Страна
US
Торговля Abpro Corporation (ABP)

Категория

Коэффициент P/B для Abpro Corporation (ABP)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Abpro Corporation, текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Abpro Corporation с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE